SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The company provides daisy players, handheld, and desktop magnifiers. Its products are used in hospitals, medical facilities, doctor's offices, weight loss centers, Fitness Centers, nursing homes, public health facilities, and retail locations. The company was formerly known as Jawon Medical Co., Ltd. and changed its name to SELVAS Healthcare, Inc. in September 2016. SELVAS Healthcare, Inc. was founded in 1993 and is headquartered in Daejeon, South Korea.
Часто задаваемые вопросы
В каком секторе работает Hana Must SPAC 2 (208370)?
Hana Must SPAC 2 относится к сектору Здравоохранение.
Какова текущая цена акций Hana Must SPAC 2 (208370)?
По последним данным, цена акций Hana Must SPAC 2 составляет 2 385 ₩, предыдущее закрытие — 2 430 ₩. За последнюю торговую сессию акции Hana Must SPAC 2 снизились на -45 ₩, что соответствует падению на -1,85%.
Выплачивает ли Hana Must SPAC 2 (208370) дивиденды?
Нет, Hana Must SPAC 2 не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Hana Must SPAC 2 (208370)?
У компании Hana Must SPAC 2 бета -0.717, что указывает на более низкую волатильность по сравнению с рынком в целом.
